Prestige Consumer Healthcare (NYSE:PBH) Releases FY23 Earnings Guidance

Prestige Consumer Healthcare (NYSE:PBHGet Rating) updated its FY23 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $4.18-$4.23 for the period, compared to the consensus estimate of $4.25. The company issued revenue guidance of $1.12-$1.13 billion, compared to the consensus revenue estimate of $1.11 billion.

Separately, StockNews.com began coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, March 31st. They set a buy rating for the company.

Prestige Consumer Healthcare stock traded up $0.27 during trading hours on Friday, hitting $53.91. 132 shares of the stock were exchanged, compared to its average volume of 232,984. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.25 and a current ratio of 2.04. The stock has a market capitalization of $2.71 billion, a P/E ratio of 14.42, a P/E/G ratio of 1.59 and a beta of 0.58. Prestige Consumer Healthcare has a 12 month low of $44.37 and a 12 month high of $63.83. The business’s 50-day moving average is $54.88 and its two-hundred day moving average is $57.76.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last issued its quarterly earnings data on Thursday, May 5th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $266.94 million for the quarter, compared to analysts’ expectations of $258.25 million. Prestige Consumer Healthcare had a net margin of 17.85% and a return on equity of 13.90%. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.79 earnings per share. On average, equities analysts predict that Prestige Consumer Healthcare will post 4.04 earnings per share for the current fiscal year.

A number of institutional investors have recently modified their holdings of the business. EverSource Wealth Advisors LLC bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $26,000. Advisor Group Holdings Inc. grew its stake in shares of Prestige Consumer Healthcare by 10.9% during the first quarter. Advisor Group Holdings Inc. now owns 3,694 shares of the company’s stock valued at $196,000 after purchasing an additional 363 shares during the last quarter. CIBC World Markets Inc. grew its stake in shares of Prestige Consumer Healthcare by 8.8% during the fourth quarter. CIBC World Markets Inc. now owns 4,387 shares of the company’s stock valued at $266,000 after purchasing an additional 353 shares during the last quarter. Schonfeld Strategic Advisors LLC grew its stake in shares of Prestige Consumer Healthcare by 19.7% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 6,700 shares of the company’s stock valued at $407,000 after purchasing an additional 1,105 shares during the last quarter. Finally, Oliver Luxxe Assets LLC bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $595,000.

About Prestige Consumer Healthcare (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Recommended Stories

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.